Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED

Active

FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED having CIN U24239MH1959PTC011347 is 66 years , 1 month & 8 days old Private Indian Company incorporated on 01 May 1959. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 20,000,000 and its paid up capital is Rs. 4,625,000. It's NIC code is 24239 (which is part of its CIN).

As per the NIC code, it is involved in Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc. . FRANCO-INDIAN PHARMACEUTICALS Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2023. Directors of FRANCO-INDIAN PHARMACEUTICALS are Errol James Desouza and Errol James Desouza.

FRANCO-INDIAN PHARMACEUTICALS ' Corporate Identification Number (CIN) is U24239MH1959PTC011347 and its registration number is 011347. Users may contact FRANCO-INDIAN PHARMACEUTICALS on its Email address - sbrahane@francoindian.com Registered address of FRANCO-INDIAN PHARMACEUTICALS is 20 DR E MOSES ROAD,,MUMBAI,Maharashtra,India-400011. Current status of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is - Active.

Key Indicators

Authorised Capital
20,000,000

as on 09/06/2025

Paid Up Capital
4,625,000

as on 09/06/2025

Company Age
66 Year, 1 Months
Last Filing with ROC
1 Year, 8 Months

Company Information

CIN U24239MH1959PTC011347
Company Status Active
Registration Number 011347
Date of Incorporation 05/01/1959
RoC ROC Mumbai
Company Age 66 years & 56 days
Authorized Capital ₹ 20000000
Paid-up capital ₹ 4625000
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc.
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2022
Date of Latest Balance Sheet 31-03-2022

Contact

Email ID sbrahane@francoindian.com
Address 20, DR. E. MOSES ROAD, MUMBAI Maharashtra India 400011
Website francoindian.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director
DEBRANJAN SINHA
02/16/2023 08048279 *****4859H 2 years
Director
SANTOSH MOHAN CHAVAN
11/30/2021 09097972 *****9554H 3 years
Director
JAGDISH PURUSHOTTAMDAS MEHTA
02/13/2023 00053296 *****6669F 2 years
Director
PASCAL POSTEL
01/01/1998 00026853 *****2763K 27 years
Director
LALSA BALGOVIND YADAV
02/22/2023 00055974 *****5076A 2 years
Director
AJIT ANANT MANGALVEDE
05/03/2023 10140076 *****5124F 2 years
Director
ALEXANDRE JOHAN POSTEL
05/07/2023 03588038 *****1315Q 2 years
Director
ERROL JAMES DESOUZA
05/15/2023 00053201 *****2202J 2 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
WARDEX PHARMACEUTICALS PRIVATE LIMITED
Active
41,98,400.00 2 Tamil Nadu
LABORATOIRES GRIFFON PRIVATE LIMITED
Active
32,06,000.00 2 West Bengal
FRANCO INDIAN THERAPEUTICS PVT. LTD.
Active
1,00,200.00 1 West Bengal
FRANCO INDIAN MEDICARE PVT LTD
Active
1,00,000.00 1 West Bengal
FRANCO-INDIAN HOLDINGS PRIVATE LIMITED
Active
7,37,50,000.00 1 Maharashtra
FRANCO INDIAN RESEARCH PRIVATE LIMITED
Active
1,00,300.00 1 Tamil Nadu
PRINCEPS PHARMACEUTICALS PRIVATE LIMITED
Active
1,00,000.00 1 Tamil Nadu
FRANCO-INDIAN REMEDIES PRIVATE LIMITED
Active
14,90,600.00 2 Tamil Nadu
MEDIBEST INVESTMENTS PRIVATE LIMITED
Amalgamated
11,50,000.00 2 Maharashtra
CURABEST INVESTMENTS PRIVATE LIMITED
Amalgamated
11,50,000.00 2 Maharashtra
PHARMABEST INVESTMENTS PRIVATE LIMITED
Amalgamated
11,50,000.00 2 Maharashtra

Charges on assets

No Data Available
Charge Holder Branch Amount Date of creation Modification Satisfaction Status
Not Available

Registered Details

CIN
U24239MH1959PTC011347
PAN
U24239MH1959PTC011347
Incorporation
2 years
Company Email
sbrahane@francoindian.com
Paid up Capital
₹ 4,625,000
Authorised Capital
₹ 20,000,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc.

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores
Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Franco-indian Pharmaceuticals Private Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Franco-indian Pharmaceuticals Private Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Franco-indian Pharmaceuticals Private Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Franco-indian Pharmaceuticals Private Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Franco-indian Pharmaceuticals Private Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Franco-indian Pharmaceuticals Private Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Franco-indian Pharmaceuticals Private Limited

What is FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED ?

FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED having CIN U24239MH1959PTC011347 is 2 years month old Private Indian Company incorporated with MCA on 15 May 2023. FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 20,000,000 and paid-up capital is 4,625,000.

What is the CIN of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED?

CIN of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is U24239MH1959PTC011347.

Where is FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED located?

Address of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is 20 dr e moses road,,mumbai,maharashtra,india-400011,.

Who are the directors of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED ?

The company has 12 directors/key management personnel Debranjan Sinha,santosh Chavan,jagdish Mehta,pascal Postel,lalsa Yadav,jagdish Mehta,debranjan Sinha,lalsa Yadav,ajit Mangalvede,alexandre Johan Postel,pascal Postel,errol Desouza,

What is the contact details of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED ?

Email : sbrahane@francoindian.com
Address : 20, DR. E. MOSES ROAD, MUMBAI Maharashtra India 400011

What does FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED do?

FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry